Loxof Infusion

Loxof Infusion

levofloxacin

Manufacturer:

Ranbaxy

Distributor:

DKLL
Concise Prescribing Info
Contents
Levofloxacin
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult ≥18 yr Acute bacterial exacerbation of chronic bronchitis 500 mg/day for 7 days. Nosocomial pneumonia; complicated skin & skin structure infections 750 mg/day for 7-14 days. Community-acquired pneumonia 500 mg/day for 7-14 days or 750 mg/day for 5 days. Acute maxillary sinusitis 500 mg/day for 10-14 days. Uncomplicated skin & skin structure infections 500 mg/day for 7-10 days. Chronic bacterial prostatitis 500 mg/day for 28 days. Complicated UTI & acute pyelonephritis 250 mg/day for 10 days. Uncomplicated UTI 250 mg/day for 3 days. To be given by slow IV infusion 60-90 min.
Contraindications
Hypersensitivity.
Special Precautions
Renal insufficiency, CNS disorder that may predispose to seizures or lower the seizure threshold. Avoid excessive exposure to sunlight. Monitor blood glucose in diabetics. Patient w/ prolonged QT interval, uncorrected hypokalemia. Pseudomembranous colitis may occur. Childn, pregnancy & lactation.
Adverse Reactions
Nausea, headache, diarrhea, insomnia, constipation, abdominal pain, dizziness, vomiting & other GI disorders, dyspepsia, vaginitis, rash, chest pain, pruritus, sinusitis, dyspnea, fatigue, flatulence, pain, back pain, rhinitis, anxiety, pharyngitis, CV disorders, convulsions & other CNS & peripheral disorders, earache, tinnitus, heart rate & rhythm disorders, abnormal hepatic function, arthralgia, arthritis, arthrosis, myalgia, osteomyelitis, skeletal pain, synovitis, tendonitis, tendon disorder.
Drug Interactions
Class IA or III antiarrhythmics, drugs containing multivalent cations eg, Mg, theophylline, warfarin, NSAIDs, antidiabetic agents.
MIMS Class
ATC Classification
J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Loxof Infusion 500 mg/100 mL
Packing/Price
(FFS vial) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in